ロード中...
Bispecific Antibodies: A New Era of Treatment for Multiple Myeloma
Despite the introduction of novel agents such as proteasome inhibitors, immunomodulatory drugs, and autologous stem cell transplant, multiple myeloma (MM) largely remains an incurable disease. In recent years, monoclonal antibody-based treatment strategies have been developed to target specific surf...
保存先:
| 出版年: | J Clin Med |
|---|---|
| 主要な著者: | , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
MDPI
2020
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7408718/ https://ncbi.nlm.nih.gov/pubmed/32659909 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/jcm9072166 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|